Lesson
Trace Desert Dust to Tissue Spherules
Coccidioides lives in arid soil. Airborne arthroconidia enter the lung and develop into tissue spherules that release endospores.
- Arid soil
- Arthroconidia
- Spherule
- Endospore
- Cell-mediated immunity
environment biology
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Map the geography
Endemic regions include much of Arizona, arid California, parts of New Mexico, Nevada, Utah, Texas, northern Mexico, and emerging areas such as eastern Washington. Travel history can matter years later.
Follow the form
Environmental hyphae fragment into arthroconidia that become airborne. In tissue, the organism forms large spherules containing endospores rather than budding yeasts.
Read host defense
Cell-mediated immunity usually contains infection. HIV, transplantation, TNF inhibition, corticosteroids, pregnancy, diabetes, and other conditions increase complicated disease risk.
Protect the laboratory
Culture can produce highly infectious arthroconidia. Alert the laboratory when Coccidioides is suspected so specimens and growth are handled with appropriate containment.
Quick check
Lesson
Name the Clinical Compartment
Disease ranges from self-limited focal pneumonia to diffuse lung injury, nonmeningeal dissemination, destructive bone disease, and chronic meningitis.
- Focal pneumonia
- Diffuse pulmonary
- Extrapulmonary
- Bone and joint
- Meningitis
syndromes risk
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Recognize pulmonary disease
Fever, cough, pleuritic pain, fatigue, headache, rash, arthralgia, adenopathy, nodules, or cavities can resemble bacterial or viral pneumonia. Persistent illness after antibacterial therapy should reopen the differential.
Recognize diffuse disease
Widespread infiltrates, hypoxemia, respiratory failure, hemodynamic instability, or rapid progression represents severe pulmonary disease and supports amphotericin induction.
Search by symptoms
Skin lesions, focal bone or joint pain, lymph-node disease, soft-tissue lesions, or neurologic symptoms direct targeted imaging and sampling. Routine whole-body imaging is unnecessary without clinical clues.
Protect the CNS
Persistent headache, nausea, cognitive change, cranial neuropathy, or gait change warrants lumbar puncture and CNS evaluation. Hydrocephalus can become a separate mechanical emergency.
Quick check
Lesson
Combine Serology With Site Evidence
Serology is central but not absolute. Timing, immune suppression, laboratory method, culture, pathology, imaging, and the suspected compartment determine diagnostic confidence.
- IgM
- IgG
- Complement fixation
- Culture
- Pathology
diagnosis serology
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Use serology thoughtfully
IgM can support early infection and IgG supports evolving or established infection. False-positive IgM and false-negative early or immunosuppressed results require clinical interpretation.
Use complement fixation longitudinally
Complement fixation titers can correlate with burden and support response monitoring, but no single titer proves or excludes dissemination. Compare trends with symptoms and imaging.
Obtain organism evidence
Respiratory, tissue, bone, skin, or CSF culture and pathology can establish site-specific disease. Notify the laboratory because cultured arthroconidia are hazardous.
Stage only where indicated
Use directed imaging or lumbar puncture when symptoms identify a possible extrapulmonary site. Routine lumbar puncture is not needed in the absence of neurologic symptoms.
Quick check
Lesson
Use an Oral Triazole for Focal Disease
Mild-to-moderate focal pulmonary disease in HIV is treated with an oral triazole. The choice depends on site, absorption, interactions, organ function, and follow-up.
- Fluconazole 400 mg
- Itraconazole loading
- Bone and joint
- TDM
- 3 to 6 months
focal treatment
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Use fluconazole
Fluconazole 400 mg orally daily is appropriate for focal pulmonary infection. Review renal function, liver tests, QT risk, pregnancy, and interacting drugs.
Use itraconazole precisely
Give conventional itraconazole 200 mg three times daily for 3 days, then 200 mg twice daily. Verify formulation, food and acidity instructions, interactions, and a serum concentration after about 2 weeks.
Prefer itraconazole for bone or joint disease
Osteoarticular disease often favors itraconazole and requires prolonged treatment, imaging, tissue evidence, structural assessment, and surgical consultation when needed.
Define focal stopping
After 3 to 6 months, stopping can be considered with clinical response, CD4 at least 250, suppressed HIV RNA, and planned chest imaging and serologic monitoring.
Quick check
Lesson
Induce Severe Disease With Amphotericin
Diffuse pulmonary or severe nonmeningeal dissemination needs amphotericin until improvement, followed by prolonged oral triazole therapy.
- Amphotericin deoxycholate
- Lipid formulation
- Clinical improvement
- Triazole transition
- At least 12 months
severe disseminated
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Choose the induction product
Amphotericin B deoxycholate 0.7 to 1 mg/kg IV daily or a lipid formulation 3 to 5 mg/kg IV daily is used. A lipid formulation is favored when renal risk is important.
Prevent predictable toxicity
Monitor creatinine, potassium, magnesium, CBC, liver tests, infusion reactions, volume, and nephrotoxins. Formulations are not interchangeable milligram for milligram.
Transition after improvement
Continue amphotericin until meaningful clinical improvement, then use fluconazole 400 mg daily or itraconazole 200 mg twice daily with exposure verification.
Treat long enough
Diffuse pulmonary or nonmeningeal disseminated disease generally requires at least 12 months. Expert review, clinical response, serology, site recovery, ART, and immune status guide discontinuation.
Quick check
Lesson
Treat Meningitis as a Lifelong System
Coccidioidal meningitis differs from other fungal meningitides: high-dose oral fluconazole is preferred, IV amphotericin alone is ineffective, hydrocephalus may need shunting, and suppression is lifelong.
- Fluconazole 800 to 1200 mg
- CSF
- Hydrocephalus
- Intrathecal amphotericin
- Lifelong
meningitis
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Use preferred therapy
Give fluconazole 800 to 1200 mg orally daily with specialist care. Alternatives include itraconazole, voriconazole, posaconazole, or isavuconazole in selected failures or intolerance.
Do not rely on IV amphotericin alone
Intravenous amphotericin alone is ineffective for coccidioidal meningitis. Refractory disease can require intrathecal amphotericin administered only by an experienced clinician.
Treat hydrocephalus mechanically
Headache, gait change, cognition, vomiting, visual symptoms, imaging, and pressure can reveal hydrocephalus. CSF shunting may be required in addition to antifungal therapy.
Continue lifelong treatment
Relapse after triazole discontinuation is very common. Continue suppressive treatment at therapeutic doses for life even after symptom control or immune recovery.
Quick check
Lesson
Protect Antifungal Exposure and Organ Safety
Long treatment courses make absorption, renal clearance, liver injury, cardiac risk, interactions, adherence, and access central to efficacy.
- Renal
- Liver
- QT
- CYP interactions
- TDM
exposure safety
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Manage fluconazole
Adjust maintenance exposure for renal function. Monitor liver tests, rash, QT risk, potassium, magnesium, and interactions with ART, warfarin, anticonvulsants, statins, and immunosuppressants.
Manage itraconazole
Document formulation and administration, obtain concentrations, and monitor liver tests, edema, heart-failure symptoms, potassium, CYP3A4 interactions, and strong inducers.
Manage amphotericin
Monitor renal function, electrolytes, CBC, infusion reactions, volume, and nephrotoxins throughout induction. A lipid product reduces but does not remove toxicity.
Manage continuity
Verify authorization, supply, swallowing, adherence, travel, monitoring access, and ownership. A preventable gap can reactivate controlled disease.
Quick check
Lesson
Coordinate ART, Prophylaxis, and Stopping
HIV control changes risk and duration. Preemptive therapy applies to a specific serologic and CD4 state, while severe CNS disease may justify individualized ART timing.
- CD4 250
- New seropositivity
- Fluconazole 400 mg
- ART
- IRIS
art prevention
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Use preemptive therapy selectively
A person with HIV, newly positive Coccidioides IgM or IgG, no active-disease evidence, and CD4 below 250 can receive fluconazole 400 mg daily. First exclude focal, diffuse, disseminated, and CNS disease.
Restore immune control
Effective ART is central. Most patients should receive coordinated ART, but profound immunosuppression with disseminated or CNS disease can justify specialist-guided delay of 4 to 6 weeks and close monitoring.
Stop focal therapy carefully
For focal pneumonia, require 3 to 6 months of response, CD4 at least 250, suppressed HIV RNA, and continued chest imaging and serologic surveillance.
Respect syndrome-specific duration
Diffuse pulmonary or nonmeningeal dissemination generally needs at least 12 months and expert review. Meningitis therapy remains lifelong regardless of immune recovery.
Quick check
Lesson
Treat Pregnancy With Gestational Precision
Pregnancy increases severe disease risk, especially later pregnancy and postpartum, while first-trimester azole exposure requires careful avoidance when feasible.
- First trimester
- Amphotericin
- Later pregnancy
- Meningitis
- Maternal-fetal care
pregnancy special
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Recognize risk
Symptomatic disease during pregnancy deserves prompt evaluation. Severe risk rises later in pregnancy and immediately postpartum, so endemic exposure with febrile pulmonary illness warrants chest imaging, serology, and cultures.
Treat first-trimester nonmeningeal disease
Amphotericin B is preferred when treatment is required. Observation or an azole can be considered only through individualized risk discussion in selected cases.
Treat later disease
Fluconazole or itraconazole can be considered after the first trimester. Continue coordinated maternal-fetal, infectious-disease, and pharmacy monitoring.
Protect meningitis control
First-trimester meningitis management can require intrathecal amphotericin or another expert strategy while avoiding systemic azole exposure. Do not create an unprotected interruption in lifelong therapy.
Quick check
Lesson
Build a Lifelong-Capable Care System
Complete care links geography, syndrome, immune host, serology, site evidence, antifungal exposure, structural complications, ART, and relapse surveillance.
- Geography
- Compartment
- Exposure
- Immune control
- Ownership
integrated case
Trace exposure, tissue form, clinical compartment, and treatment across one connected disease system.
Define disease and reach
Document endemic exposure, pulmonary severity, focal extrapulmonary symptoms, neurologic findings, immune status, and competing diagnoses.
Own evidence
Track serology and complement fixation trends, cultures, pathology, imaging, and CSF when indicated. Notify the laboratory before culture handling.
Own delivery
Verify exact product, dose, formulation, route, loading, administration, organ monitoring, interactions, concentration, access, adherence, and transition criteria.
Own duration
Separate focal 3-to-6-month treatment, disseminated treatment of at least 12 months, and lifelong meningitis suppression. Align ART and surveillance with the correct syndrome.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.